As Medicare begins implementing negotiated Maximum Fair Prices (MFPs) under the Inflation Reduction Act, pharmaceutical manufacturers face a new operational reality.
Beyond pricing negotiations, organizations must ensure accurate execution of MFP across claims processing, reimbursement workflows, and financial reporting systems. Without robust operational controls, risks such as duplicate discounts with the 340B program and inconsistent chargeback processing can quickly emerge.
This white paper explores the execution and orchestration capabilities required to operationalize MFP successfully, including integrated data reconciliation, governance models, and pricing infrastructure.
Download the white paper to understand how manufacturers can transform pricing operations to enable compliant, transparent, and scalable MFP execution.
